Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.23.457229Source: DataRank Database

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.628. It has been cited 65 times.

N/A

0.628DataRank · unranked

Scored on demand from live citation data

Open Access65 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: greenTopics (4)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.628

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (47)

Mark M. Painter ORCID,Sokratis A. Apostolidis ORCID,Divij Mathew ORCID,Wenzhao Meng ORCID,Aaron M. Rosenfeld ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: 1T32AR076951-01

Training Program/Rheumatic Diseases

National Institutes of Health

Grant: 5P01AI108545-08

Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity

National Institutes of Health

Grant: 5R01AI152236-05

Development of vaccines targeting a tick-borne phlebovirus

National Institutes of Health

Grant: 5R01AI105343-03

Cellular and transcriptional control of exhausted CD8 T cells lineage dynamics

National Institutes of Health

Grant: 5U19AI149680-03

Engineering T cells to Provide Durable Control of HIV-1 Replication

National Institutes of Health

Grant: 5R01AI155577-02

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

National Institutes of Health

Grant: 4T32AI055400-14

Training in Emerging Infectious Diseases

National Institutes of Health

Grant: 2U19AI082630-06

Reversal of Immune Failure with Viral Cure in Chronic HCV Infection

National Institutes of Health

Grant: 5T32CA009140-12

IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/08/23/2021.08.23.457229.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.08.23.457229

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8404899

Europe_PMChttps://europepmc.org/article/PPR/PPR387420

Europe_PMChttps://europepmc.org/api/fulltextRepo?pprId=PPR387420&type=FILE&fileName=EMS134152-pdf.pdf&mimeType=application/pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Article

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

N/A

1.4DataRank · unranked

The Lancet Respiratory Medicine(2020)

co-cited

10.1016/s2213-2600(20)30079-5

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

N/A

1.4DataRank · unranked

The Lancet Respiratory Medicine(2020)

co-cited

10.1016/s2213-2600(20)30076-x

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

N/A

1.6DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)30183-5

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

N/A

1.2DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.05.015

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

N/A

1.1DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.08.017

Immunology of COVID-19: Current State of the Science

N/A

1.1DataRank · unranked

Immunity(2020)

co-cited

10.1016/j.immuni.2020.05.002

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

N/A

14.5DataRank · unranked

Science(2020)

co-cited

10.1126/science.abc8511

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

N/A

1.1DataRank · unranked

Nature Immunology(2020)

co-cited

10.1038/s41590-020-0782-6

T cell responses in patients with COVID-19

N/A

1.0DataRank · unranked

Nature reviews. Immunology(2020)

co-cited

10.1038/s41577-020-0402-6

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

N/A

1.0DataRank · unranked

Journal of Microbiology Immunology and Infection(2020)

co-cited

10.1016/j.jmii.2020.03.005